Last update:

Medications news

Medications

Long-acting injectable HIV therapy offers hope for those unable to take pills

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found.

Medications

No link seen between preop GLP-1 receptor agonist use and postop aspiration pneumonia

Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a study published online March 4 in JAMA Network Open.

Medications

FDA approves TNKase for acute ischemic stroke

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Medications

Common malaria drug repurposed to fight cancer

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that. Pyronaridine has been ...

Medications

Obinutuzumab efficacious for renal response in lupus nephritis

For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than standard therapy alone, according ...

Medications

Antidepressant users see average of 2% weight gain, finds study

A recent study led by the Hospital del Mar Research Institute and published by Frontiers in Psychiatry demonstrates the link between antidepressants and weight gain. Using follow-up data from participants in the REGICOR study ...

Medications

FDA approves Datroway for HR-positive, HER2-negative breast cancer

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative ...